Skip to main content
. 2012 Dec 13;5:49–64. doi: 10.4137/IJTR.S10627

Figure 3.

Figure 3

Kynurenine aminotransferase I (KAT I) in the frontal cortex and cerebellum of different pathological subgroups of patients after HIV-1 infection.

Notes: Values represent the mean ± SEM of following groups: Control (CO, n = 16); Pathological subgroups: HIV in brain tissue by immunocytochemistry (HIV, n = 6); opportunistic infection (OPP, n = 15); malignant lymphoma (LY, n = 5); infarction of brain (INF, n = 5) and glial dystrophy (GD, n = 5). Significance: *P < 0.05; **P < 0.01; ***P < 0.001 compared with control. Statistical analysis for frontal cortex: a, b indicates statistical significance at P < 0.05; a, c indicates statistical significance at P < 0.001; analysis of variance: F = 1.9226, P = 0.1088. Statistical analysis for cerebellum: a, b indicates statistical significance at P < 0.05; a, c indicates statistical significance at P < 0.01, a, d indicates statistical significance at P < 0.001, one-way analysis of variance, F = 3.2938, P = 0.0126.